About Viruj Pharma
Viruj Pharma is a Chemicals & Materials company based in Hyderabad (India). API manufacturing and pharmaceutical services in India. It operates in the Chemicals & Materials and Healthcare sectors. The company has 44 employees. Its Indian entity Viruj Pharmaceuticals Private Limited reported revenue of ₹18.20 Cr. Viruj Pharma offers products and services including Fluconazole and Fexofenadine. Its focus areas include Pharmaceuticals, Chemical Manufacturing, Process Development and Flow Chemistry.
Company details
Viruj Pharma is identified as a key API manufacturer based in Hyderabad, India, where a wide range of active pharmaceutical ingredients is produced, including Fluconazole and Fexofenadine. Strict quality standards such as Schedule M and ICH Q7 are adhered to, with processes involving continuous and batch manufacturing. Safety and environmental regulations are complied with through regular training and efforts to minimize impacts. The company serves global markets by developing complex APIs for therapy advantages, focusing on scale-up and commercial production.
- Headquarters Hyderabad, India
- Employees 44
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Legal Name Viruj Pharmaceuticals Private Limited
- Date of Incorporation 11 Aug, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹18.20 Cr
FY 2025 · -44% YoY
- Net Loss-₹4.67 Cr
FY 2025 · -26% margin
- EBITDA-₹3.83 Cr
FY 2025 · -21% margin
- Employee Count44
Associated legal entities of Viruj Pharma
Viruj Pharma operates through Viruj Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Viruj Pharmaceuticals Private Limited CIN U24100TG2014PTC095202 | Active | 11 Aug 2014 | Hyderabad, Telangana | ₹18.2 Cr | 44 | 2 | View details |
Products & Services of Viruj Pharma
Viruj Pharma offers a comprehensive portfolio of products and services, including Fluconazole and Fexofenadine.
Fluconazole is produced as an active pharmaceutical ingredient for antifungal treatments.
Fexofenadine is manufactured as an active pharmaceutical ingredient for antihistamine applications.
Board of directors of Viruj Pharmaceuticals Private Limited (Viruj Pharma)
Viruj Pharmaceuticals Private Limited is the primary company behind Viruj Pharma. The board of Viruj Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Venkata Ranga Narasimha Mahesh Pidimarri, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Ranga Narasimha Mahesh Pidimarri DIN 06899296 | Managing Director | 11 Aug 2014 | 12 yrs 2 mo | Viruj Pharmaceuticals Private Limited |
| Kavita Pidimarri DIN 09361006 | Director | 14 Jun 2024 | 2 yrs 4 mo | Viruj Pharmaceuticals Private Limited |
Financials of Viruj Pharma
Figures of Viruj Pharmaceuticals Private Limited, the primary company behind Viruj Pharma, for FY 2025. Revenue was ₹18.20 Cr (-44% year on year). Net loss was -₹4.67 Cr (-26% margin). EBITDA was -₹3.83 Cr (-21% margin). Revenue has grown at a compounded annual rate of -42% over three years and -9% over five years.
- ₹18.20 CrRevenue · FY 2025 · -44% YoY
- -₹4.67 CrNet loss · -26% margin
- -₹3.83 CrEBITDA · -21% margin
- ₹2 LakhPaid-up capital
- 44Employees (provident fund records)
- -42%Revenue CAGR, 3 years
- -9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Viruj Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Viruj Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Viruj Pharma
Viruj Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Viruj Pharma has 44 employees.
The primary company behind Viruj Pharma, Viruj Pharmaceuticals Private Limited, reported revenue of ₹18.20 Cr for FY 2025, down 44% year on year.
Viruj Pharma is identified as a key API manufacturer based in Hyderabad, India, where a wide range of active pharmaceutical ingredients is produced, including Fluconazole and Fexofenadine. Strict quality standards such as Schedule M and ICH Q7 are adhered to, with processes involving continuous and batch manufacturing. Safety and environmental regulations are complied with through regular training and efforts to minimize impacts. The company serves global markets by developing complex APIs for therapy advantages, focusing on scale-up and commercial production.
Viruj Pharma offers Fluconazole and Fexofenadine.
Viruj Pharma operates through Viruj Pharmaceuticals Private Limited.
The legal entities of Viruj Pharma currently have 2 directors, including Venkata Ranga Narasimha Mahesh Pidimarri, Kavita Pidimarri.